| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Newman James W. Jr. is a Director at ADIL. Recent filings cover 9 purchases and 0 sales. Those positions are worth an estimated $86K at current prices.
Newman James W. Jr.'s largest disclosed position is in ADIL as Director, worth about $86K. Net of sales, the recent Form 4 record there shows accumulation of 74,644 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 30, 2021 | ADIL Adial Pharmaceuticals, Inc. | Director | Buy | 25,000 | $2.69 | $67,300.00 | +31.3% | -25.1% | -91.9% | |
| Nov 26, 2021 | ADIL Adial Pharmaceuticals, Inc. | Director | Buy | 10,000 | $2.85 | $28,500.00 | +40.9% | -23.5% | -90.2% | |
| Mar 27, 2020 | ADIL Adial Pharmaceuticals, Inc. | Director | Buy | 19,644 | $1.36 | $26,769.40 | +84.4% | - | - | |
| Jul 31, 2018 | ADIL Adial Pharmaceuticals, Inc. | Director | Buy | 20,000 | $0.00 | - | +14.2% | - | - |